Highlight 
 
 
 
 
 
 
   
 
 
 
 
   
www.vanefist.eu
CLINICAL RESEARCH 2004, June 24
 
The Poitiers hospital (CHU) stakes its claim
 

The clincial investigations entrusted to the CHU should be growing appreciably in the months to come.  
The emergence of the clinical research center directed by Professor François Guilhot presently enables the CHU to bolster its claim to fame in various disciplines, among which oncology-hematology, diabetes and clinical epidemiology may fairly be said to have star billing.

Just like other establishments, the Poitiers CHU is doing all it can to develop clinical research within its premises. In fact, this is one of the prime objectives of the general manager, Jean-Pierre Dewitte. In a move essential to its upcoming growth, the clinical research center (CRC) set up in March 1992 underwent thoroughgoing restructuring late last year. The person entrusted with the coordination was Pr. François Guilhot, general delegate in clinical research and eminent head of the Poitiers hospital's hematology-oncology laboratory.

François Guilhot intends to make his international renown redound to the benefit of the CHU. Author of widely recognized research works on chronic myeloid leukemia, the interested party is no newcomer to publication. "My team and I have been working on this theme since 1984, so he insists. In 1997, I had a first paper appear in the New England Journal of Medicine. I also published an article on this disease in December 2003 in Blood, a major impact factor." In the watchful eyes of the INSERM, these publications furnish multiple proof of high seriousness.

Obtaining a quality label

The objective? To obtain as soon as possibke the INSERM label and thereby transform the CRC into a Center of Clinical Investigation. "The CHU has submitted to the Institute this type of request", indicates Sarah Guyon, the administrative manager. Awaiting this precious label, the Clinical Resarch delegation of the Poitou-Charentes region has expressed the wish to reorient the CRC in three guiding directions: onco-hematology with Professors Guilhot, Tourani (medical oncology department head), Daban (oncology radiotherapy), Bataille (neurosurgery) and Kraimps (visceral surgery); diabetes and its renal complications, with Dr. Hadjaj; as well as clinical epidemiology and the prevention of cardiovascular diseases, with Pr. Herpin (cardiologist).

On the fringes of the CRC, other research activities have likewise been cropping up in the clinical departments. One example is dermatology, in which Pr. Guilhot has been conducting numerous investigations on behalf of private promoters, notably in "dealing with cases of psoriasis and chronic urticaria", states Sarah Guyon. In the anesthesia and intensive care areas, Pr. Debaene and his team are also studying antibiotic resistance in nosocomial infections…

http://www.chu-poitiers.fr
Hospital of Poitiers: The new emergency area is open
 
Home-based hospitalization: A unit comes into being
 
The Poitiers Biopole in the Walloon area of Belgium
 
Health for breakfast
 



BIOalternatives diversifies its markets
read...
 
Two Poitiers-based projects awarded
read...
 
IUT pores over biofuels
read...
 
Poitiers, the biotechnology capital
read...
 
PAREXEL wagers on the human factor
read...
 
Saunier and associates wish to diversify
read...
 
Biocydex and BioXtract move forward hand in hand
read...
 
The grass of champions
read...
 
Ianesco steadfastly believes in its future
read...
 
A tumorotheque, what is the purpose it serves?
read...
 
TechnAvOx has turned the corner
read...
 
Larime is aiming for 40 beds in Poitiers
read...
 
Poitiers is out to promote its research
read...
 
A true Biopole milestone
read...
 
A regional cancerology pole in the pipeline for 2007
read...
 
Nobel prize winners in Poitiers
read...
 
A platform offering numerous advantages
read...
 
@rtMolecule fashions in its own way
read...
 
It’s plastic, it’s fantastic
read...
 
The Poitiers hospital (CHU) stakes its claim
read...
 
BIOalternatives exports its know-how
read...
 
The physiological and computer science engineering program turns 30
read...
 
The Biopole takes center stage at Investiga
read...
 
 
   
  Legal mentions
English / Anglais Français / French